BPMCBlueprint Medicines Corp

$0.00
$0.00
(0.00%)
Today
Updated:
Reported EarningsJul 30
Mkt Cap$8.37B
Vol2.98M
News
all
press releases
News Placeholder
Why Is Acadia (ACAD) Up 26.1% Since Last Earnings Report?
Zacks
News Placeholder
Blueprint Medicines Stock Lands Several Downgrades After Sanofi’s Buyout Deal, But Retail Bulls Keep The Faith
Analysts revised price targets near the deal’s $129-per-share valuation.
Stocktwits
News Placeholder
Sanofi Signs a $9.5B Agreement to Acquire Blueprint Medicines
Zacks
News Placeholder
Sanofi To Buy Blueprint Medicines For Up To $9.5B: Retail Sees More Acquisition Offers From European Pharma Companies
Sanofi will pay $129 per share in cash at closing, representing a 27% premium to Blueprint’s closing price on Friday of $101.35.
Stocktwits
<
...
1
>

Advertisement|Remove ads.